ClinicalTrials.govpublic full text
Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
prostate cancer, prostatic diseases, neoplasms, prostatic neoplasms, hormones, androgen antagonists, vaccines, peptide vaccines, adjuvants, immunological, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979585
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.